Cargando…

Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting

BACKGROUND: Genome editing by CRISPR-Cas9 technology allows large-scale screening of gene essentiality in cancer. A confounding factor when interpreting CRISPR-Cas9 screens is the high false-positive rate in detecting essential genes within copy number amplified regions of the genome. We have develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Iorio, Francesco, Behan, Fiona M., Gonçalves, Emanuel, Bhosle, Shriram G., Chen, Elisabeth, Shepherd, Rebecca, Beaver, Charlotte, Ansari, Rizwan, Pooley, Rachel, Wilkinson, Piers, Harper, Sarah, Butler, Adam P., Stronach, Euan A., Saez-Rodriguez, Julio, Yusa, Kosuke, Garnett, Mathew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088408/
https://www.ncbi.nlm.nih.gov/pubmed/30103702
http://dx.doi.org/10.1186/s12864-018-4989-y
_version_ 1783346826855841792
author Iorio, Francesco
Behan, Fiona M.
Gonçalves, Emanuel
Bhosle, Shriram G.
Chen, Elisabeth
Shepherd, Rebecca
Beaver, Charlotte
Ansari, Rizwan
Pooley, Rachel
Wilkinson, Piers
Harper, Sarah
Butler, Adam P.
Stronach, Euan A.
Saez-Rodriguez, Julio
Yusa, Kosuke
Garnett, Mathew J.
author_facet Iorio, Francesco
Behan, Fiona M.
Gonçalves, Emanuel
Bhosle, Shriram G.
Chen, Elisabeth
Shepherd, Rebecca
Beaver, Charlotte
Ansari, Rizwan
Pooley, Rachel
Wilkinson, Piers
Harper, Sarah
Butler, Adam P.
Stronach, Euan A.
Saez-Rodriguez, Julio
Yusa, Kosuke
Garnett, Mathew J.
author_sort Iorio, Francesco
collection PubMed
description BACKGROUND: Genome editing by CRISPR-Cas9 technology allows large-scale screening of gene essentiality in cancer. A confounding factor when interpreting CRISPR-Cas9 screens is the high false-positive rate in detecting essential genes within copy number amplified regions of the genome. We have developed the computational tool CRISPRcleanR which is capable of identifying and correcting gene-independent responses to CRISPR-Cas9 targeting. CRISPRcleanR uses an unsupervised approach based on the segmentation of single-guide RNA fold change values across the genome, without making any assumption about the copy number status of the targeted genes. RESULTS: Applying our method to existing and newly generated genome-wide essentiality profiles from 15 cancer cell lines, we demonstrate that CRISPRcleanR reduces false positives when calling essential genes, correcting biases within and outside of amplified regions, while maintaining true positive rates. Established cancer dependencies and essentiality signals of amplified cancer driver genes are detectable post-correction. CRISPRcleanR reports sgRNA fold changes and normalised read counts, is therefore compatible with downstream analysis tools, and works with multiple sgRNA libraries. CONCLUSIONS: CRISPRcleanR is a versatile open-source tool for the analysis of CRISPR-Cas9 knockout screens to identify essential genes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12864-018-4989-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6088408
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60884082018-08-17 Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting Iorio, Francesco Behan, Fiona M. Gonçalves, Emanuel Bhosle, Shriram G. Chen, Elisabeth Shepherd, Rebecca Beaver, Charlotte Ansari, Rizwan Pooley, Rachel Wilkinson, Piers Harper, Sarah Butler, Adam P. Stronach, Euan A. Saez-Rodriguez, Julio Yusa, Kosuke Garnett, Mathew J. BMC Genomics Methodology Article BACKGROUND: Genome editing by CRISPR-Cas9 technology allows large-scale screening of gene essentiality in cancer. A confounding factor when interpreting CRISPR-Cas9 screens is the high false-positive rate in detecting essential genes within copy number amplified regions of the genome. We have developed the computational tool CRISPRcleanR which is capable of identifying and correcting gene-independent responses to CRISPR-Cas9 targeting. CRISPRcleanR uses an unsupervised approach based on the segmentation of single-guide RNA fold change values across the genome, without making any assumption about the copy number status of the targeted genes. RESULTS: Applying our method to existing and newly generated genome-wide essentiality profiles from 15 cancer cell lines, we demonstrate that CRISPRcleanR reduces false positives when calling essential genes, correcting biases within and outside of amplified regions, while maintaining true positive rates. Established cancer dependencies and essentiality signals of amplified cancer driver genes are detectable post-correction. CRISPRcleanR reports sgRNA fold changes and normalised read counts, is therefore compatible with downstream analysis tools, and works with multiple sgRNA libraries. CONCLUSIONS: CRISPRcleanR is a versatile open-source tool for the analysis of CRISPR-Cas9 knockout screens to identify essential genes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12864-018-4989-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-13 /pmc/articles/PMC6088408/ /pubmed/30103702 http://dx.doi.org/10.1186/s12864-018-4989-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Iorio, Francesco
Behan, Fiona M.
Gonçalves, Emanuel
Bhosle, Shriram G.
Chen, Elisabeth
Shepherd, Rebecca
Beaver, Charlotte
Ansari, Rizwan
Pooley, Rachel
Wilkinson, Piers
Harper, Sarah
Butler, Adam P.
Stronach, Euan A.
Saez-Rodriguez, Julio
Yusa, Kosuke
Garnett, Mathew J.
Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
title Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
title_full Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
title_fullStr Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
title_full_unstemmed Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
title_short Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
title_sort unsupervised correction of gene-independent cell responses to crispr-cas9 targeting
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088408/
https://www.ncbi.nlm.nih.gov/pubmed/30103702
http://dx.doi.org/10.1186/s12864-018-4989-y
work_keys_str_mv AT ioriofrancesco unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT behanfionam unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT goncalvesemanuel unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT bhosleshriramg unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT chenelisabeth unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT shepherdrebecca unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT beavercharlotte unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT ansaririzwan unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT pooleyrachel unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT wilkinsonpiers unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT harpersarah unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT butleradamp unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT stronacheuana unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT saezrodriguezjulio unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT yusakosuke unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting
AT garnettmathewj unsupervisedcorrectionofgeneindependentcellresponsestocrisprcas9targeting